Back to User profile » Dr Meng Zhang

Papers published by Dr Meng Zhang:


Characterizing CD8+ TEMRA Cells in CP/CPPS Patients: Insights from Targeted Single-Cell Transcriptomic and Functional Investigations

Zhang F, Ge Q, Meng J, Chen J, Liang C, Zhang M

ImmunoTargets and Therapy 2024, 13:111-121

Published Date: 26 February 2024

Targeting CXCL12/CXCR4 Signaling with AMD3100 Might Selectively Suppress CXCR4+ T-Cell Chemotaxis Leading to the Alleviation of Chronic Prostatitis

Zhang M, Liu Y, Chen J, Chen L, Zhang L, Chen X, Hao Z, Liang C

Journal of Inflammation Research 2022, 15:2551-2566

Published Date: 21 April 2022

Prognostic Role of Prothrombin Time Activity, Prothrombin Time, Albumin/Globulin Ratio, Platelets, Sex, and Fibrinogen in Predicting Recurrence-Free Survival Time of Renal Cancer

Bian Z, Meng J, Niu Q, Jin X, Wang J, Feng X, Che H, Zhou J, Zhang L, Zhang M, Liang C

Cancer Management and Research 2020, 12:8481-8490

Published Date: 15 September 2020

The correlation between microRNA-221/222 cluster overexpression and malignancy: an updated meta-analysis including 2693 patients

Zhang P, Zhang M, Han R, Zhang K, Ding H, Liang C, Zhang L

Cancer Management and Research 2018, 10:3371-3381

Published Date: 10 September 2018

Association of polymorphisms in interleukin-8 gene with cancer risk: a meta-analysis of 22 case–control studies

Zhang M, Fang T, Wang K, Mei H, Lv Z, Wang F, Cai Z, Liang C

OncoTargets and Therapy 2016, 9:3727-3737

Published Date: 22 June 2016

Association between two interleukin-2 gene polymorphisms and cancer susceptibility: a meta-analysis

Zhang M, Tan X, Huang J, Xie L, Wang H, Shi J, Lu W, Lv Z, Mei H, Liang C

OncoTargets and Therapy 2016, 9:2181-2192

Published Date: 19 April 2016

Association between L55M polymorphism in Paraoxonase 1 and cancer risk: a meta-analysis based on 21 studies

Chen L, Lu W, Fang L, Xiong H, Wu X, Zhang M, Wu S, Yu D

OncoTargets and Therapy 2016, 9:1151-1158

Published Date: 4 March 2016